Oragenics Chases Vaccine for Niche Markets
UF startup and UF Innovate | Sid Martin Biotech graduate Oragenics, a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, seeks to be a major player in the Super Bowl of the pharmaceutical industry: a COVID-19 vaccine.
Biotech Firm Raises $20 Million, Sees Progress on COVID-19 Vaccine
UF startup and UF Innovate | Sid Martin Biotech graduate company Oragenics, Inc. has raised $20 million from the sale of common stock and will use some of the funding to boost its research into a Covid-19 vaccine.
Unsure About the COVID-19 Vaccine? UF Health’s Chief Epidemiologist Has Answers
Nicole M. Iovine, M.D., Ph.D., chief epidemiology officer for the University of Florida Health Shands Hospital system, addresses key issues related to overcoming vaccine hesitancy.
